This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis | MicrobiomeTrials
← Back to trials NCT03887273
Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis Recruiting PHASE1, PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2022-09-20Est. Completion: 2027-07
Enrollment target: 9 participantsLocations University of Texas Southwestern Medical Center, Dallas, Texas, United States Other microbiome trials you might be interested in Rare Diseases Neuromyelitis Optica Spectrum Disorder (NMOSD)
This is a multi-centre, retrospective-prospective, single-arm, non-interventional (observational) cohort study with seco…
Novosibirsk, Russia Completed Feb 26, 2026
B-cell Mediated Autoimmune Disorders
The main objective of the study is to determine the recommended phase 2 dose (RP2D) of Azercabtagene zapreleucel (azer-c…
La Jolla, United States Est. completion Dec 1, 2027